The cervical solution marks the completion of the NuVasive Reline fixation portfolio for complex deformity from occiput to sacrum SAN DIEGO, Sept. 28, 2022 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with…
NuVasive Launches Reline Cervical for Posterior Cervical Fusion as Part of the C360 Portfolio
